Search

Author/Creator Pearse, William B.

1. A phase I/II trial of brentuximab vedotin plus rituximab as frontline therapy for patients with immunosuppression-associated CD30+ and/or EBV + lymphomas. Issue 14 (6th December 2021)

Authors:
Pearse, William B.; Petrich, Adam M.; Gordon, Leo I.; Karmali, Reem; Winter, Jane N.; Ma, Shuo; Kaplan, Jason B.; Behdad, Amir; Klein, Andreas; Jovanovic, Borko; Helenowski, Irene; Smith, Sonali M.; Evens, Andrew M.; Pro, Barbara
Journal:
Leukemia & lymphoma
Issue:
Volume 62:Issue 14(2021)
Page Start:
3493
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search